{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for norethindrone root_Display\ Name in Display Name (approximate match)
Status:
Excipient
Class:
POLYMER
Status:
Excipient
Source:
9.2mg ORAL TABLET, EXTENDED RELEASE
Source URL:
Class:
POLYMER
Status:
Other
Class:
POLYMER
Status:
Other
Class:
POLYMER
Status:
Other
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
21 CFR 343
(2021)
Source URL:
First approved in 2021
Source:
21 CFR 343
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
M020
(2024)
Source URL:
First approved in 2017
Source:
21 CFR 348
Source URL:
Class:
POLYMER